DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/bf7220/global_generics) has announced the addition of the "Global Generics" report to their offering.
The Generics market remains a major growth area in the global healthcare market, with market growth significantly higher than that of patented drugs and the overall pharmaceutical market. The industry has witnessed a decade long sales euphoria as volume and value sales of generic drugs continue to increase.
The Global Generics market was valued at US$123 billion in 2010, and has been estimated to reach US$ 180 billion by 2014, at a CAGR of 10.6% during 2011-14.
Several big players have been moving into the generic drugs market - spearheaded by leading pharma companies and specialist pharma organisations. The top 10 players together accounts for more then 40% of the global generics market. Teva was the leading generics company in the year 2010 with annual revenue of US$16.1 billion. The global generics industry is undergoing a phase of consolidation. Global pharma players continue to penetrate the burgeoning emerging markets by acquisition of domestic generics and manufacturing companies.
SCOPE OF THE REPORT
This report discusses in detail about the major generic markets while giving information on their market size, recent trends, major players, generics pricing and outlook for the market. The report also analyses the factors that drive the growth of the generics industry.
- Overview of the generics industry in terms of size, geographical and Therapeutic segmentation
- Top 20 products in world's largest generics market
- Industry Trends
- Major Markets ( North America, Europe and Asia Pacific)
- Major Players - their business and financial profile, key strategies, R&D pipeline and outlook for the company.
- Amount & Area of R&D spend of major generic companies
- Regulations governing generics, Key patent expiries in the future
- Outlook for the global generics industry for the next five years
Companies Mentioned:
- Teva Pharmaceutical Industries Ltd
- Mallinckrodt
- Sandoz
- Mylan Inc
- Hospira, Inc
- Watson Pharmaceuticals
- STADA
- Cipla Ltd
- Par Pharma
- Dr. Reddy's Laboratories Ltd
For more information visit http://www.researchandmarkets.com/research/bf7220/global_generics